Real-World Efficacy of Hydrus Microstent With OMNI Surgical System in Combination With Phacoemulsification: a Retrospective Analysis
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY
Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Subjects with h/o CEIOL/OMNI/Hydrus (chosen based on subjects on more than 1 medication pre-operatively) with at least 3 years of follow up data
• have Glaucoma
Locations
United States
Arizona
Barnet Dulaney Perkins Eye Center
RECRUITING
Mesa
Contact Information
Primary
Derek J Arnson, Master of Education
derek.arnson@researchavp.com
4804201005
Backup
Christine Funke, Medical Doctor
christine.funke@BDPEC.com
4804201005
Time Frame
Start Date: 2025-03-31
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 300
Treatments
Single Group/Cohort retrospectively utilized
This will be 300 eyes that have undergone the combination of Phacoemulsification, OMNI Canaloplasty and Hydrus microstent that will successfully lower IOP in ethnically-diverse patients with Open Angle Glaucoma
Related Therapeutic Areas
Sponsors
Collaborators: Alcon, a Novartis Company
Leads: Barnet Dulaney Perkins Eye Centers